Leveraging Clinical Tumor-Profiling Programs to Achieve Comprehensive Germline-Inclusive Precision Cancer Medicine.
作者信息
AlDubayan Saud H
机构信息
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
The Broad Institute of MIT and Harvard, Cambridge, MA.
出版信息
JCO Precis Oncol. 2019 Dec;3:1-3. doi: 10.1200/PO.19.00108.
PMID:35100696
Abstract
摘要
Zotero 插件